32 Projects
Completed under PLI Scheme for Promotion of Pharma
·
32
Projects with Cumulative Installed Capacity of 56,679 MT per annum have been Completed
under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting
Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs)
in the Country
·
Against
targeted investment of Rs. 3,938 crores, investments worth Rs. 4,024 crores have
been made under scheme
·
249
applications were received, of which 48 projects have been selected for
manufacturing of identified bulk drugs. 13 of these projects are implemented by
10 Micro, Small and Medium Enterprises (MSMEs).
[ABS News Service/10.08.2024]
The
Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing
of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical
Ingredients (APIs) in the Country with a financial outlay of Rs. 6,940 crores was approved by the Cabinet to boost domestic manufacturing of
bulk drugs in the country, reduce import dependence and improve our supply chain
resilience. The production period under the scheme is from FY 2022-23 to FY 2028-29.
Under
the scheme, 249 applications were received, of which 48 projects have been selected
for manufacturing of identified bulk drugs. 13 of these projects are implemented
by 10 Micro, Small and Medium Enterprises (MSMEs).
Annexure
Production
Linked Incentive scheme for Promotion of Domestic Manufacturing of Critical Key
Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients
(APIs) in the Country.
S.
No. |
State |
Name
of the Company |
Product |
1 |
Andhra
Pradesh |
Lyfius
Pharma Pvt. Ltd. |
Penicillin
G |
2 |
Granules
India Limited |
Dicyandiamide
(DCDA) |
|
3 |
Andhra
Organics Limited |
Olmesartan |
|
4 |
Andhra
Organics Limited |
Sulfadiazine |
|
5 |
Andhra
Organics Limited |
Telmisartan |
|
6 |
Hetero
Drugs Limited |
Carbidopa |
|
7 |
Hetero
Drugs Limited |
Levodopa |
|
8 |
Honour
Lab Limited |
Lopinavir |
|
9 |
Honour
Lab Limited |
Vitamin
B6 |
|
10 |
Kreative
Actives Private Limited (MSME) |
Diclofenac
Sodium |
|
11 |
Gujarat |
Macleods
Pharmaceutical Limited |
Rifampicin |
12 |
Meghmani LLP |
Para
Amino Phenol |
|
13 |
Amoli
Organics Private Limited |
Diclofenac
Sodium |
|
14 |
Aviran Pharmachem Private Limited (MSME) |
Artesunate |
|
15 |
Globela
Industries Pvt. Ltd (MSME) |
Norfloxacin |
|
16 |
Globela
Industries Pvt. Ltd (MSME) |
Ofloxacin |
|
17 |
Vital
Laboratories Private Limited (MSME) |
Levofloxacin |
|
18 |
Vital
Laboratories Private Limited (MSME) |
Ofloxacin |
|
19 |
Himachal
Pradesh |
Kinvan
Private Limited |
Clavulanic
Acid |
20 |
Jammu
& Kashmir |
Orchid
Bio-Pharma Limited |
7
ACA |
21 |
Karnataka |
Natural
Biogenex Private Limited |
Betamethasone |
22 |
Natural
Biogenex Private Limited |
Dexamethasone |
|
23 |
Natural
Biogenex Private Limited |
Prednisolone |
|
24 |
Madhya
Pradesh |
Karnataka
Antibiotics and Pharmaceuticals Limited |
7
ACA |
25 |
Symbiotec Pharmalab Private Limited |
Prednisolone |
|
26 |
Maharashtra |
Sadhana
Nitro Chem Ltd. (MSME) |
Para
Amino Phenol |
27 |
Alta
Laboratories Limited |
Aspirin |
|
28 |
Lifetech
Sciences (MSME) |
Ritonavir |
|
29 |
RMC
Performance Chemicals Private Limited (MSME) |
Aspirin |
|
30 |
Sudarshan
Pharma Industries Ltd. (MSME) |
Vitamin
B1 |
|
31 |
Sudarshan
Pharma Industries Ltd. (MSME) |
Vitamin
B6 |
|
32 |
Punjab |
Centrient
Pharmaceuticals India Private Limited |
Atorvastatin |
33 |
Rajasthan |
Rajasthan
Antibiotics Limited |
Meropenem |
34 |
Tamil
Nadu |
Global
Pharma Healthcare Private Limited (MSME) |
Ofloxacin |
35 |
K P
Manish Global Ingredients Pvt. Ltd. |
Artesunate |
|
36 |
Telangana |
Emmennar
Pharma Pvt. Ltd. (MSME) |
1,1
Cyclohexane Diacetic Acid (CDA) |
37 |
Hindys Lab
Pvt. Ltd. |
1,1
Cyclohexane Diacetic Acid (CDA) |
|
38 |
Anasia Lab
Private Limited |
Losartan |
|
39 |
Anasia Lab
Private Limited |
Olmesartan |
|
40 |
Dasami Lab
Pvt. Ltd. |
Carbamazepine |
|
41 |
Dasami Lab
Pvt. Ltd. |
Oxcarbazepine |
|
42 |
Hazelo Lab
Pvt. Ltd. |
Vitamin
B6 |
|
43 |
Hetero
Drugs Limited |
Levofloxacin |
|
44 |
Hetero
Drugs Limited |
Oxcarbazepine |
|
45 |
Hindys Lab
Pvt. Ltd. |
Acyclovir |
|
46 |
Honour
Lab Limited |
Levetiracetam |
|
47 |
Honour
Lab Limited |
Valsartan |
|
48 |
MSN
Life Sciences Pvt. Ltd. |
Levofloxacin |
This
information was given by the Union Minister of State for Chemicals and Fertilizers
Smt Anupriya Patel in Lok Sabha
in reply to a question on 9 August, 2024.